• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助 T 细胞 17 型应答在 COVID-19 中的作用。

The Role of Th17 Response in COVID-19.

机构信息

Department of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Bialystok, Poland.

出版信息

Cells. 2021 Jun 19;10(6):1550. doi: 10.3390/cells10061550.

DOI:10.3390/cells10061550
PMID:34205262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8235311/
Abstract

COVID-19 is an acute infectious disease of the respiratory system caused by infection with the SARS-CoV-2 virus (Severe Acute Respiratory Syndrome Coronavirus 2). Transmission of SARS-CoV-2 infections occurs through droplets and contaminated objects. A rapid and well-coordinated immune system response is the first line of defense in a viral infection. However, a disturbed and over-activated immune response may be counterproductive, causing damage to the body. Severely ill patients hospitalised with COVID-19 exhibit increased levels of many cytokines, including Interleukin (IL)-1β, IL-2, IL-6, IL-7, IL-8, IL-10, IL-17, granulocyte colony stimulating factor (G-CSF), monocyte chemoattractant protein 1 (MCP-1) and tumor necrosis factor (TNF). Increasing evidence suggests that Th17 cells play an important role in the pathogenesis of COVID-19, not only by activating cytokine cascade but also by inducing Th2 responses, inhibiting Th1 differentiation and suppressing Treg cells. This review focuses on a Th17 pathway in the course of the immune response in COVID-19, and explores plausible targets for therapeutic intervention.

摘要

新型冠状病毒肺炎(Corona Virus Disease 2019,COVID-19)是由严重急性呼吸综合征冠状病毒 2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)感染引起的呼吸系统急性传染病。SARS-CoV-2 感染的传播途径为飞沫传播和接触传播。迅速且协调良好的免疫系统反应是病毒感染的第一道防线。然而,紊乱和过度激活的免疫反应可能适得其反,导致身体损伤。COVID-19 住院重症患者表现出多种细胞因子水平升高,包括白细胞介素(interleukin,IL)-1β、IL-2、IL-6、IL-7、IL-8、IL-10、IL-17、粒细胞集落刺激因子(granulocyte colony stimulating factor,G-CSF)、单核细胞趋化蛋白 1(monocyte chemoattractant protein 1,MCP-1)和肿瘤坏死因子(tumor necrosis factor,TNF)。越来越多的证据表明,辅助性 T 细胞 17(T helper cell 17,Th17)细胞在 COVID-19 的发病机制中发挥重要作用,不仅通过激活细胞因子级联反应,还通过诱导 Th2 反应、抑制 Th1 分化和抑制 T 调节细胞来发挥作用。本综述重点关注 COVID-19 免疫反应过程中的 Th17 途径,并探讨了治疗干预的可能靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47cc/8235311/3428516965f0/cells-10-01550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47cc/8235311/3428516965f0/cells-10-01550-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47cc/8235311/3428516965f0/cells-10-01550-g001.jpg

相似文献

1
The Role of Th17 Response in COVID-19.辅助 T 细胞 17 型应答在 COVID-19 中的作用。
Cells. 2021 Jun 19;10(6):1550. doi: 10.3390/cells10061550.
2
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.用于测量 COVID-19 患者体内 SARS-CoV-2 特异性反应的全血检测。
Clin Microbiol Infect. 2021 Feb;27(2):286.e7-286.e13. doi: 10.1016/j.cmi.2020.09.051. Epub 2020 Oct 10.
3
COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.COVID-19 免疫病理学,重点关注 Th17 反应和基于细胞的免疫调节治疗:潜在靶点和挑战。
Scand J Immunol. 2022 Feb;95(2):e13131. doi: 10.1111/sji.13131. Epub 2022 Jan 3.
4
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.辅助性 T 细胞亚群反应是 COVID-19 进展的决定因素。
Front Cell Infect Microbiol. 2021 Feb 26;11:624483. doi: 10.3389/fcimb.2021.624483. eCollection 2021.
5
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.无症状、轻度和重症有症状 SARS-CoV-2 感染患者的病毒载量、淋巴细胞亚群和细胞因子:一项回顾性研究。
Virol J. 2021 Jun 12;18(1):126. doi: 10.1186/s12985-021-01597-x.
6
SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.SARS-CoV-2 介导的免疫系统激活及其在免疫治疗中的潜在应用。
Med Res Rev. 2021 Mar;41(2):1167-1194. doi: 10.1002/med.21756. Epub 2020 Nov 13.
7
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.新型冠状病毒-19(SARS-CoV-2)通过白细胞介素-1(IL-1)引起细胞因子风暴导致 COVID-19 的急性重症肺部炎症:一种有前途的抑制策略。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1971-1975. doi: 10.23812/20-1-E.
8
T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications.辅助性 T 细胞 17 应答与严重急性呼吸综合征冠状病毒 2:一种具有潜在治疗意义的免疫应答类型。
Viral Immunol. 2021 Apr;34(3):190-200. doi: 10.1089/vim.2020.0177. Epub 2021 Feb 23.
9
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者:体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
10
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.

引用本文的文献

1
A pain from the nose to the head: neurological commitment during long COVID.从鼻子到头部的疼痛:长期新冠期间的神经学关联
Inflamm Res. 2025 Sep 16;74(1):127. doi: 10.1007/s00011-025-02085-6.
2
Altered Gut Microbiota and Predicted Immune Dysregulation in Early Childhood SARS-CoV-2 Infection.幼儿感染新冠病毒后肠道微生物群的改变及预测的免疫失调
Microorganisms. 2025 Aug 12;13(8):1879. doi: 10.3390/microorganisms13081879.
3
Hypoxia Exacerbates Inflammatory Signaling in Human Coronavirus OC43-Infected Lung Epithelial Cells.缺氧加剧人冠状病毒OC43感染的肺上皮细胞中的炎症信号传导。

本文引用的文献

1
Human Dental Pulp Stem Cells Modulate Cytokine Production by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients.人牙髓干细胞调节2019冠状病毒病患者外周血单个核细胞的细胞因子产生
Front Cell Dev Biol. 2021 Feb 5;8:609204. doi: 10.3389/fcell.2020.609204. eCollection 2020.
2
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma.2019年冠状病毒病康复期血浆中的细胞因子和趋化因子水平
Open Forum Infect Dis. 2020 Nov 26;8(2):ofaa574. doi: 10.1093/ofid/ofaa574. eCollection 2021 Feb.
3
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.
Biomolecules. 2025 Aug 8;15(8):1144. doi: 10.3390/biom15081144.
4
Machine Learning Reassessment of Serum Immune Factors Shows No Unique Immune Profiles Linked to Disease Outcomes in SARS-CoV-2-infected Patients at Hospital Admittance.对血清免疫因子的机器学习重新评估显示,在SARS-CoV-2感染患者入院时,没有与疾病结局相关的独特免疫特征。
Eur J Immunol. 2025 Jul;55(7):e70001. doi: 10.1002/eji.70001.
5
An updated review on systemic glucocorticoids in the prevention and treatment of bronchopulmonary dysplasia.关于全身用糖皮质激素预防和治疗支气管肺发育不良的最新综述。
Pediatr Discov. 2023 Jun 12;1(1):e6. doi: 10.1002/pdi3.6. eCollection 2023 Jun.
6
Lung Volume Change Assessment in Moderate and Severe COVID-19 Using CT Volumetry.使用CT容积测量法评估中度和重度新冠肺炎患者的肺容积变化
Diagnostics (Basel). 2025 Jun 9;15(12):1465. doi: 10.3390/diagnostics15121465.
7
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
8
The role of inflammatory gene polymorphisms in severe COVID-19: a review.炎症基因多态性在重症新型冠状病毒肺炎中的作用:综述
Virol J. 2024 Dec 20;21(1):327. doi: 10.1186/s12985-024-02597-3.
9
Immunomodulatory effect of bovine lactoferrin during SARS-CoV-2 infection.牛乳铁蛋白在 SARS-CoV-2 感染期间的免疫调节作用。
Front Immunol. 2024 Oct 17;15:1456634. doi: 10.3389/fimmu.2024.1456634. eCollection 2024.
10
Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren's syndrome.干燥综合征唾液腺纤维化发病机制中的免疫和非免疫介质。
Front Immunol. 2024 Oct 14;15:1421436. doi: 10.3389/fimmu.2024.1421436. eCollection 2024.
新冠病毒疾病中失调的免疫反应和细胞因子释放风暴(CRS)。
Int Immunopharmacol. 2021 Jan;90:107225. doi: 10.1016/j.intimp.2020.107225. Epub 2020 Nov 27.
4
Cytokine profile and disease severity in patients with COVID-19.COVID-19 患者的细胞因子谱与疾病严重程度。
Cytokine. 2021 Jan;137:155323. doi: 10.1016/j.cyto.2020.155323. Epub 2020 Sep 30.
5
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.用于测量 COVID-19 患者体内 SARS-CoV-2 特异性反应的全血检测。
Clin Microbiol Infect. 2021 Feb;27(2):286.e7-286.e13. doi: 10.1016/j.cmi.2020.09.051. Epub 2020 Oct 10.
6
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与肾素-血管紧张素系统分子相互作用的见解
Front Cell Dev Biol. 2020 Sep 16;8:559841. doi: 10.3389/fcell.2020.559841. eCollection 2020.
7
How COVID-19 induces cytokine storm with high mortality.新冠病毒如何引发高死亡率的细胞因子风暴。
Inflamm Regen. 2020 Oct 1;40:37. doi: 10.1186/s41232-020-00146-3. eCollection 2020.
8
Compartmental immunophenotyping in COVID-19 ARDS: A case series.COVID-19 相关急性呼吸窘迫综合征的隔室免疫表型:病例系列。
J Allergy Clin Immunol. 2021 Jan;147(1):81-91. doi: 10.1016/j.jaci.2020.09.009. Epub 2020 Oct 23.
9
Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.COVID-19 中的细胞因子过度反应:住院 COVID-19 患者的泪液细胞因子谱。
Exp Eye Res. 2020 Nov;200:108253. doi: 10.1016/j.exer.2020.108253. Epub 2020 Sep 16.
10
Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities.解析 IL-23 信号级联反应,寻找新的治疗机会。
Cells. 2020 Sep 7;9(9):2044. doi: 10.3390/cells9092044.